Presentation TCT 2017 Crushing and Chewing Oral P2Y12 Receptor Inhibitors: Pharmacodynamic and Clinical Impact Presenter: Fabiana Rollini October 30, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 CAD Pharma Up Next Presentation TCT 2017 Switching Between Oral P2Y12 Receptor Inhibitors: When and How? Presenter: Matthew J. Price October 30, 2017 More slides + Presentation TCT 2017 Switching to and From Cangrelor: When and How? Presenter: Dominick J. Angiolillo October 30, 2017 Presentation TCT 2017 Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment Presenter: Thomas Engstroem October 30, 2017 We Recommend
Presentation TCT 2017 Switching Between Oral P2Y12 Receptor Inhibitors: When and How? Presenter: Matthew J. Price October 30, 2017
Presentation TCT 2017 Switching to and From Cangrelor: When and How? Presenter: Dominick J. Angiolillo October 30, 2017
Presentation TCT 2017 Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment Presenter: Thomas Engstroem October 30, 2017